Cystic Fibrosis Foundation - About the Cystic Fibrosis Foundation

2006 Press Releases

12/20/06	CF Foundation Publicly Reports Care Center Data for National Care Center Network
11/02/06	Denver to Host Largest Gathering of Cystic Fibrosis Scientists and Clinicians in the World
11/02/06	Cystic Fibrosis Foundation Launches New Web Site
07/13/06	CFFT Awards Milestone Payment to Predix for Drug Discovery Progress
06/01/06	Foundation and CombinatoRx Collaborate to Develop Novel Therapeutics for Cystic Fibrosis
05/31/06	U.S. Congress Recognizes National Awareness Month
05/17/06	Compound Known as VX-770 Begins Clinical Trials
04/05/06	FDA Grants SLIT Amikacin Orphan Drug Designation; Clinical Trials Planned
04/05/06	CF Foundation Takes GREAT STRIDES for Cystic Fibrosis
03/23/06	CF Foundation Commits $13 Million More to Vertex
02/14/06	Copernicus to Further Develop Non-Viral Gene Therapy for Cystic Fibrosis With Continued Support from Cystic Fibrosis Foundation Therapeutics
02/07/06	Yasoo Health to Develop First-of-Its Kind Multi-vitamin for CF
01/30/06	Inspire Announces FDA Go-Ahead for Phase 3 Trial on INS37217 (denufosol)
01/18/06	Saltwater Solution Offers Novel Therapy for Cystic Fibrosis Patients
01/18/06	Researchers find effective, cheap treatment for cystic fibrosis lung disease
01/12/06	Vertex and Foundation Announce New Agreement
12/06/05	PTC Therapeutics, Inc. Research Study Advances to Phase II PTC124 is an orally administered drug targeting nonsense mutations and is being studied as a potential treatment for CF.
03/16/05	Cystic Fibrosis Foundation Therapeutics and Alnylam Initiate Collaboration to Discover RNAi Therapeutic to Treat CF -- CFFT to Provide $1.5 Million